Skip to content

Long-term monitoring of children with intestinal failure

Long-term monitoring of children with intestinal failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27840
Enrollment
62
Registered
2016-09-01
Start date
2015-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal failure

Interventions

None listed

Sponsors

Erasmus Medical Center - Sophia Children's Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children, newly diagnosed with intestinal failure in the Erasmus MC-Sophia Children's Hospital. Three groups of children will be included: 1. Children with congenital gastro-intestinal anomalies with involvement of the small intestine, independent of expected use of parenteral nutrition. 2. Neonates with an expected use of parenteral nutrition ≥ 1 week after a gastrointestinal intervention (laparotomy). 3. Children with a (suspected) motility disorder or intrinsic disorder of the intestinal mucosa with an expected use of parenteral nutrition > 2 weeks and children with an expected use of parenteral nutrition ≥ 1 week after a gastrointestinal intervention (laparotomy) after the neonatal period. Furthermore, children already known with intestinal failure who receive parenteral nutrition at home and visit the intestinal failure outpatient clinic will be included, both in the Erasmus MC - Sophia Children's Hospital and the AMC - Emma Children's Hospital.

Exclusion criteria

Exclusion criteria: Participating in an intervention study, interfering with primary outcome of this study. Absence of written informed consent Insufficient knowledge of the Dutch language

Design outcomes

Primary

MeasureTime frame
Body composition measured, defined by %BF Parenteral nutrition (time-weighted area under the curve for % of total kilocalories provided by parenteral nutrition and duration of PN)

Secondary

MeasureTime frame
Growth, defined by weight, length, head circumference and calculated SD scores. Mid-upper arm circumference scores. Bone health, defined by bone mineral density (g/cm2), bone mineral content (g) and bone mineral apparent density (g/cm3), bone age and bone health index.

Contacts

Public ContactJM Hulst

Erasmus MC - Sophia Children's Hospital

j.hulst@erasmusmc.nl0107036049

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 4, 2026